Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 8/2007

01-08-2007 | Short Communication

Cancer and complementary medicine: an international perspective

Authors: Vinjar Fønnebø, Marja Verhoef, Charlotte Paterson

Published in: Supportive Care in Cancer | Issue 8/2007

Login to get access

Excerpt

Throughout the world, people with cancer have a relatively high mortality rate, a relatively low cure rate and often experience multiple symptoms from cancer and its treatment. Cancer patients, understandably, explore all potential treatment options, including complementary and alternative medicine (CAM). Whilst most patients prefer having their diseases treated as close to home as possible, there is an increasing trend for patients to seek treatment in other countries and to explore a variety of cultural treatment paradigms. This trend particularly applies to CAM, which even more than conventional medicine shows considerable international variation in the type of treatment options available. …
Literature
1.
Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Belle Brown J, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18:2515–2521PubMed
2.
Corner J, Harewood J, Maslin-Prothero S, Lewith G, Maher EJ, Young T, Gwilliam C, Roffe L, Haviland J, Davies R (2006) A study of the use of complementary and alternative therapies among people undergoing cancer treatment: a quantitative and qualitative study. University of Southampton
3.
Eastwood HL (2000) Complementary therapies: the appeal to general practitioners. Med J Aust 173:95–98PubMed
4.
Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer—a systematic review. Cancer 83:777–782PubMedCrossRef
5.
6.
Fønnebø V, Grimsgaard S, Walach H et al (2007) Researching complementary and alternative treatments—the gatekeepers are not at home. BMC Med Res Methodol 7:7PubMedCrossRef
7.
Howie JGR, Heaney DJ, Maxwell M, Walker JJ (1998) A comparison of the Patient Enablement Instrument (PEI) against two established satisfaction scales as an outcome measure of primary care consultations. Fam Pract 15:165–171PubMedCrossRef
8.
Launsø L, Drageset BJ, Fønnebø V, Jacobson JS, White JD, Salamonsen A, Horneber M, Egeland E (2006) Exceptional disease courses after the use of CAM: selection, registration, medical assessment, and research. An international perspective. J Altern Complement Med 12:607–613PubMedCrossRef
9.
Mercer SW (2002) Empathy and quality of care. Br J Gen Pract 52:S9–S12PubMed
10.
Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AMA, Platin N, Kearney N, Patiraki E (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:655–663PubMedCrossRef
11.
Nagel G, Hoyer H, Katenkamp D (2004) Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey. Support Care Cancer 12:789–796PubMedCrossRef
12.
Navo MA, Phan J, Vaughan C, Lynn Palmer J, Michaud L, Jones KL, Bodurka DC, Basen-Engquist K, Hortobagyi GN, Kavanagh JJ, Smith JA (2004) An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 22:671–677PubMedCrossRef
13.
Paterson C, Britten N (2000) In pursuit of patient-centered outcomes: a qualitative evaluation of the Measure Yourself Medical Outcome Profile. J Health Serv Res Policy 5:27–36PubMed
14.
Paterson C, Thomas K, Manasse A, Cooke H, Peace G (2007) Measure Yourself Concerns and Wellbeing (MYCaW): an individualised questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement Ther Med 15:38–45PubMedCrossRef
15.
16.
Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR (2004) Knowledge of and attitudes toward complementary and alternative therapies: a national multicentre study of oncology professionals in Norway. Eur J Cancer 40:529–535PubMedCrossRef
17.
Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4:274–286PubMedCrossRef
18.
Verhoef MJ, Vanderheyden LC, Dryden T, Mallory D, Ware M (2006) Evaluating complementary and alternative medicine interventions: in search of appropriate patient-centered outcome measures. BMC Complement Altern Med 6:38CrossRef
19.
Whole systems research in cancer care—report of meeting in Tromsø (Sommaroy), 14–16 September 2005. (2006) Complement Therap Med 14:157–164
Metadata
Title
Cancer and complementary medicine: an international perspective
Authors
Vinjar Fønnebø
Marja Verhoef
Charlotte Paterson
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 8/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0287-y

Other articles of this Issue 8/2007

Supportive Care in Cancer 8/2007 Go to the issue

Short Communication

Twenty years of therapeutic touch in a Canadian cancer agency: lessons learned from a case study of integrative oncology practice

Original Article

The status of complementary therapy services in Canadian palliative care settings

Original Article

Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM)

Review Article

Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team

Editorial

Evaluating supportive cancer care: are we missing an opportunity?

Original Article

How to summarise and report written qualitative data from patients: a method for use in cancer support care
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits